Astellas Sues Chinese Rival To Block Generic Bladder Drug
Japanese pharmaceutical group Astellas Pharma Inc. has hit a Chinese rival with a suit to stop it from launching a generic version of Astellas' brand-name bladder medication Myrbetriq....To view the full article, register now.
Already a subscriber? Click here to view full article